Author:
Erondu Ngozi,Desai Mehul,Ways Kirk,Meininger Gary
Publisher
American Diabetes Association
Subject
Advanced and Specialised Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference24 articles.
1. U.S. Food and Drug Administration. FDA drug safety communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood [article online], 2015. Available from http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm. Accessed 19 May 2015
2. SGLT inhibition and euglycaemic diabetic ketoacidosis;Hine;Lancet Diabetes Endocrinol,2015
3. Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet;Hayami;J Diabetes Investig
4. Ketoacidosis occurs in both Type1 and Type2 diabetes a population-based study from Northern Sweden
Cited by
268 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献